Twinbeech Capital LP Buys Shares of 42,154 Encompass Health Co. (NYSE:EHC)

Twinbeech Capital LP bought a new stake in Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 42,154 shares of the company's stock, valued at approximately $3,893,000.

Other large investors have also recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. purchased a new stake in shares of Encompass Health in the fourth quarter valued at $152,953,000. Norges Bank purchased a new position in Encompass Health in the 4th quarter valued at about $100,637,000. Raymond James Financial Inc. purchased a new position in Encompass Health in the 4th quarter valued at about $77,944,000. Jennison Associates LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth about $52,094,000. Finally, Farallon Capital Management LLC grew its holdings in shares of Encompass Health by 15,266.7% during the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock worth $42,573,000 after buying an additional 458,000 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Ratings Changes

EHC has been the topic of a number of analyst reports. Truist Financial restated a "buy" rating and set a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. UBS Group upped their target price on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Barclays increased their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, KeyCorp lifted their price target on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Eight research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus target price of $120.86.

Insider Buying and Selling at Encompass Health

In related news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the sale, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock worth $16,034,082 over the last quarter. 2.00% of the stock is owned by corporate insiders.

Encompass Health Trading Up 0.1%

Shares of EHC traded up $0.13 during trading hours on Monday, hitting $118.74. The stock had a trading volume of 388,011 shares, compared to its average volume of 699,207. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $121.96. The firm has a market cap of $11.97 billion, a P/E ratio of 26.62, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company's fifty day simple moving average is $107.85 and its 200 day simple moving average is $101.40.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm's revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.12 earnings per share. Equities research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.